快速康复护理在中老年骨科围手术期的应用效果分析

目的 探讨快速康复护理在中老年骨科围手术期的应用效果,并评估其安全性和有效性。方法 选取北京积水潭医院新街口院区2018年7月至2021年8月收治的240例需行手术治疗的中老年患者,通过随机双盲法将其分为试验组和对照组各120例。对照组采用常规护理方式,男72例,女48例;年龄50～75岁,平均(63.2±3.3)岁。试验组采取快速康复护理,男70例,女50例;年龄51～76岁,平均(63.7±.3.5)岁。比较两组患者的术后并发症、康复进程以及护理满意度。结果 试验组术后并发症发生率15.0%,明显低于对照组的37.5%,差异有统计学意义(P<0.05);试验组平均卧床时间、下床训练时间、住院时间均明显低于对照组,差异有统计学意义(P<0.05);试验组的护理满意度为95.0%,高于对照组的90.8%,差异有统计学意义(P<0.05)。结论 采用快速康复护理可明显改善中老年骨科患者围手术期的并发症发生率,增强治疗效果,缩短住院时间。     

不同抗凝起点预防粗隆间骨折患者下肢深静脉血栓的临床对比研究

[目的]探讨不同抗凝起点对股骨粗隆间骨折患者下肢深静脉血栓(DVT)发生率的影响。[方法]2009年4月²013年6月,符合纳入条件的患者131例,男76例,女55例,年龄平均(69.1±4.2)岁,随机分为2组,其中试验组70例,对照组61例,试验组于受伤住院后即开始口服利伐沙班,术前24 h停药,拔除引流管6 h后继续使用,对照组仅在术后拔除引流管6 h后开始口服利伐沙班,抗凝药物应用至术后5周,其他治疗相同。统计学分析评估两者围手术期的出血量和血栓发生率。[结果]在治疗期间,两组患者皆未出现严重的器官出血及切口周围血肿等并发症。切口出血量试验组(459.4±132.7)ml,对照组(420.1±150.9)ml,术后切口引流量试验组(108.2±17.1)ml,对照组(115.4±32.6)ml,两组间切口出血量及术后引流量无明显统计学差异(P>0.05),实验组在治疗期间共发生DVT患者3例(4.2%),对照组共发生9例(14.7%),两组间DVT发生率具有显著统计学差异(P<0.05)。[结论]患者入院后早期抗凝,尤其是在"抗凝空白期"进行正规的抗凝治疗,不增加出血风险,能够有效的降低围手术期DVT的发生率。     

52例高龄肺癌病人的外科治疗分析

目的分析高龄肺癌患者围手术期的管理及其有效性与安全性。方法手术治疗的52例高龄肺癌患者,平均年龄75岁,行全肺切除2例,单肺叶切除33例,双肺叶切除10例,右肺袖状切除2例,肺楔形切除5例。行根治性手术48例（92.3%）,姑息性手术者4例（7.7%）。结果本组无围术期死亡,术后并发症17例（32.6%）,其中肺不张5例,肺部感染6例,心衰8例,室上性心动过速3例,心绞痛2例,下肢静脉栓塞1例,均经积极治疗痊愈出院。结论高龄肺癌患者在加强围手术期管理的前提下行外科手术治疗是安全有效的。     

小剂量布比卡因复合芬太尼腰硬联合麻醉应用于老年患者的临床研究

目的 研究小剂量布比卡因复合芬太尼腰硬联合麻醉应用于高龄患者的可行性.方法 选择拟行下腹部及下肢手术的高龄患者共60例,采用完全随机法分为2组:小剂最布比卡因复合芬太尼试验组(S组,n=30)及单纯布比卡因对照组(C组,n=30),评价两组的阻滞效果,观察两组低血压,心律失常,恶心、呕吐,寒战的发生率以及治疗低血压的麻黄碱应用.结果 两组患者均可产生可靠的麻醉效果,S组术中低血压发生率为13.3%,显著低于对照组(26.7%);试验组心律失常的发生率为16.7%显著低于对照组(43.3%),试验组与对照组相比,低血压需要麻黄素十预的患者例数显著减少;试验组恶心、呕吐的发生率显著低于对照组.两组寒战反应的发生率均较低,差异无统计学意义.结论 在实施卜腹部和下肢手术的高龄患者,小剂量布比卡因复合芬太尼腰硬联合麻醉可保持心血管系统稳定,并可减少恶心、呕吐等副作用的发生.     

老年髋关节周围骨折围手术期应用低分子肝素预防下肢深静脉血栓的研究

目的探讨应用低分子肝素围手术期预防髋关节周围骨折下肢深静脉血栓(DVT)发生的有效性和安全性。方法选取髋关节周围骨折患者70例,随机分为两组,对照组行物理方法预防;实验组行物理方法加低分子肝素预防。比较两组DVT和并发症发生率。结果对照组术前7例DVT形成,发生率为18.42%,试验组发生率为0%,差异有统计学意义(P0.05);对照组31例中术后8例DVT形成,实验组32例中术后2例发生DVT;差异有统计学意义(P0.05)。无一例发生出血。结论应用低分子肝素能有效预防髋部骨折患者围手术期DVT的发生。     

骨科大手术围手术期止血及抗凝药物的选择

骨科大手术包括全膝关节、全髋关节置换及髋部周围骨折所行手术。一方面行骨科大手术的患者术后因静脉血流缓慢、静脉壁损伤和血液高凝状态等原因,往往具有较高的血栓形成风险,易发生下肢深静脉血栓(DVT)或肺栓塞(PE)即静脉血栓栓塞(VTE),严重影响术后的恢复甚至有致死风险,基于此原因,围手术期抗凝不容忽视。另一方面,骨科大手术围手术期出血风险较高,抗凝虽能较好地预防血栓,但同时也增加了骨科大手术围手术期本身存在的出血风险,故抗凝与出血在围手术期须达到一种平衡,以获得最好的抗凝效果及最小的出血风险。     

下肢动脉硬化性闭塞症介入治疗围手术期并发症分析

目的 总结下肢动脉硬化性闭塞症介入治疗围手术期相关并发症的防治经验.方法 对207例下肢动脉硬化件闭塞症行介入治疗,统计围手术期各种并发症的发生情况,分析并发症的发生率与泛大西洋介入协会(transAtlantic inter-society consensus,TASC)分型分级之间的关系以及糖尿病和冠心病对重要脏器并发症发生率的影响.结果 本组207例,介入手术成功190例.17例失败,其中13例为介入操作失败、4例死于术后重要脏器并发症.围手术期并发症包括穿刺点出血12例、假性动脉瘤4例、消化道出血2例、动脉破裂6例、脑梗塞8例、急性心衰9例、呼衰13例、肾衰6例、支架内血栓形成5例和蓝趾综合征1例.在本组患者的TASC分型中,股腘动脉病变介入治疗并发症的发生率为39.84%(51/128),高于主髂型的18.99%(15/79)(P<0.05);患有糖尿病以及合并糖尿病和冠心病患者重要脏器并发症的发生率分别为27.66%(13/47)和24.49%(12/49),高于无合并症患者的5%(2/40)(P<0.05).结论 下肢动脉硬化性闭塞症介入治疗围手术期并发症发生率较高可能与术中操作不当、病变类型复杂及合并糖尿病和冠心病有关,术前注意合并症的处理及术中选择合理治疗方式、缩短手术时间等可减少并发症的发生.     

下肢动脉硬化性闭塞症介入治疗围手术期并发症分析

目的 总结下肢动脉硬化性闭塞症介入治疗围手术期相关并发症的防治经验.方法 对207例下肢动脉硬化件闭塞症行介入治疗,统计围手术期各种并发症的发生情况,分析并发症的发生率与泛大西洋介入协会(transAtlantic inter-society consensus,TASC)分型分级之间的关系以及糖尿病和冠心病对重要脏器并发症发生率的影响.结果 本组207例,介入手术成功190例.17例失败,其中13例为介入操作失败、4例死于术后重要脏器并发症.围手术期并发症包括穿刺点出血12例、假性动脉瘤4例、消化道出血2例、动脉破裂6例、脑梗塞8例、急性心衰9例、呼衰13例、肾衰6例、支架内血栓形成5例和蓝趾综合征1例.在本组患者的TASC分型中,股腘动脉病变介入治疗并发症的发生率为39.84%(51/128),高于主髂型的18.99%(15/79)(P<0.05);患有糖尿病以及合并糖尿病和冠心病患者重要脏器并发症的发生率分别为27.66%(13/47)和24.49%(12/49),高于无合并症患者的5%(2/40)(P<0.05).结论 下肢动脉硬化性闭塞症介入治疗围手术期并发症发生率较高可能与术中操作不当、病变类型复杂及合并糖尿病和冠心病有关,术前注意合并症的处理及术中选择合理治疗方式、缩短手术时间等可减少并发症的发生.     

下肢动脉硬化性闭塞症介入治疗围手术期并发症分析

目的 总结下肢动脉硬化性闭塞症介入治疗围手术期相关并发症的防治经验.方法 对207例下肢动脉硬化件闭塞症行介入治疗,统计围手术期各种并发症的发生情况,分析并发症的发生率与泛大西洋介入协会(transAtlantic inter-society consensus,TASC)分型分级之间的关系以及糖尿病和冠心病对重要脏器并发症发生率的影响.结果 本组207例,介入手术成功190例.17例失败,其中13例为介入操作失败、4例死于术后重要脏器并发症.围手术期并发症包括穿刺点出血12例、假性动脉瘤4例、消化道出血2例、动脉破裂6例、脑梗塞8例、急性心衰9例、呼衰13例、肾衰6例、支架内血栓形成5例和蓝趾综合征1例.在本组患者的TASC分型中,股腘动脉病变介入治疗并发症的发生率为39.84%(51/128),高于主髂型的18.99%(15/79)(P<0.05);患有糖尿病以及合并糖尿病和冠心病患者重要脏器并发症的发生率分别为27.66%(13/47)和24.49%(12/49),高于无合并症患者的5%(2/40)(P<0.05).结论 下肢动脉硬化性闭塞症介入治疗围手术期并发症发生率较高可能与术中操作不当、病变类型复杂及合并糖尿病和冠心病有关,术前注意合并症的处理及术中选择合理治疗方式、缩短手术时间等可减少并发症的发生.     

下肢动脉硬化性闭塞症介入治疗围手术期并发症分析

目的 总结下肢动脉硬化性闭塞症介入治疗围手术期相关并发症的防治经验.方法 对207例下肢动脉硬化件闭塞症行介入治疗,统计围手术期各种并发症的发生情况,分析并发症的发生率与泛大西洋介入协会(transAtlantic inter-society consensus,TASC)分型分级之间的关系以及糖尿病和冠心病对重要脏器并发症发生率的影响.结果 本组207例,介入手术成功190例.17例失败,其中13例为介入操作失败、4例死于术后重要脏器并发症.围手术期并发症包括穿刺点出血12例、假性动脉瘤4例、消化道出血2例、动脉破裂6例、脑梗塞8例、急性心衰9例、呼衰13例、肾衰6例、支架内血栓形成5例和蓝趾综合征1例.在本组患者的TASC分型中,股腘动脉病变介入治疗并发症的发生率为39.84%(51/128),高于主髂型的18.99%(15/79)(P<0.05);患有糖尿病以及合并糖尿病和冠心病患者重要脏器并发症的发生率分别为27.66%(13/47)和24.49%(12/49),高于无合并症患者的5%(2/40)(P<0.05).结论 下肢动脉硬化性闭塞症介入治疗围手术期并发症发生率较高可能与术中操作不当、病变类型复杂及合并糖尿病和冠心病有关,术前注意合并症的处理及术中选择合理治疗方式、缩短手术时间等可减少并发症的发生.     

Is anticoagulation indicated for asymptomatic postoperative calf vein thrombosis?

The purpose of this study was to determine the effect of anticoagulation on the incidence of thrombotic propagation and pulmonary embolism in patients with calf vein thrombosis after total hip or total knee arthroplasty. Patients undergoing arthroplasties had prospective surveillance for postoperative deep vein thrombosis by both bilateral contrast venography and venous duplex scanning. Calf vein thrombosis was documented by venography in 42 patients (50 limbs), including 29 of 253 patients undergoing total hip arthroplasty (11.4%) and 13 of 99 patients undergoing total knee arthroplasty (13%). Of patients on whom follow-up duplex scans were performed, heparin followed by warfarin anticoagulation was used in 11 (13 limbs) and withheld in 21 (25 limbs). Propagation of thrombosis to the popliteal or superficial femoral vein or both was detected by serial duplex scanning in 3 of 13 treated limbs (23%) and 2 of 25 untreated limbs (8%), (p = 0.43). All thrombus propagations were detected within 2 weeks of the operative procedure. There were no pulmonary emboli or deaths. Propagation of asymptomatic calf vein thrombosis after arthroplasty was not influenced by anticoagulation, suggesting that postoperative calf vein thrombosis need not be routinely treated. Serial venous duplex scanning is useful to identify the occasional patient in whom thrombotic propagation requiring anticoagulation develops.     

老年人下肢动脉硬化闭塞症腔内治疗效果分析

目的 分析老年人下肢动脉硬化闭塞症腔内治疗的临床效果及影响预后的因素.方法 回顾性总结2006年1月至2008年11月收治的86例(98条肢体)下肢动脉硬化闭塞症老年患者的临床资料.本组患者男性56例,女性30例;年龄60～82岁,平均(70±6)岁.临床症状包括重度间歇性跛行54条肢体,静息痛28条肢体,肢体溃疡11条肢体,严重坏疽5条肢体.主髂动脉病变25条肢体,股腘动脉段病变33条肢体,胫腓动脉病变8条肢体,髂股腘动脉多节段病变32条肢体.全部患者接受下肢动脉腔内治疗,总结围手术期要点及影响预后的主要因素.结果 急诊手术8条肢体,择期手术90条肢体.单纯行球囊成形10条肢体,球囊成形+支架植入88条肢体.手术成功率95.9%,围手术期严重并发症5例(5.1%),其中心肌梗死2例,一期大腿截肢2例,不可逆造影剂肾病1例.无围手术期死亡.全组83例患者术后随访1～35个月,平均(18±10)个月,随访率96.5%.随访期内死亡2例,病死率2.3%.血管一期通畅率83.7%,二期通畅率94.9%.踝关节以上截肢4例,保肢率95.9%;另有6例行截趾或截足.因素分析显示,治疗效果与糖尿病史、缺血程度和病变范围相关.结论 下肢动脉腔内重建具有微创、安全以及可重复性等优点,应作为治疗老年下肢缺血首先考虑的治疗方法.糖尿病史、缺血程度和病变范围是影响下肢动脉腔内重建效果的主要因素.     

Aortocoronary artery graft during early and late phases of acute myocardial infarction

From April, 1968, to August, 1972, 30 patients received one to three emergency saphenous vein grafts during acute myocardial infarction. In all but 1 patient, acute myocardial infarction occurred while the patients were in the hospital awaiting coronary angiography or myocardial revascularization.The patients were divided into two groups: those in the early and those in the late phases of acute myocardial infarction, depending on the time interval between the onset of chest pain and operation. Twenty-four patients (early phase) received grafts within 10 hours after the onset of infarction, and 18 of these 24 patients underwent operation within 4 hours after infarction. Two patients included in this group sustained myocardial infarctions in the operating room during elective myocardial revascularization procedures; another patient was brought to the operating room following cardiac arrest and was supported by internal cardiac massage throughout the opening of the chest and cardiac cannulation. Six patients (late phase) received grafts from three to fourteen days after acute infarction because of postinfarction angina. Only 1 patient was in cardiogenic shock prior to operation.Two patients, both from the early phase group, died in the postoperative period; and 1 patient died seven months postoperatively from a noncardiac cause. Twenty-five of 27 surviving patients became asymptomatic, and 2 patients continue to have mild angina (Functional Class II). Sixteen patients with 24 grafts were restudied in the postoperative period, and 22 of the grafts were found to be patent.This experience suggests that early operative intervention in acute myocardial infarction by the saphenous vein graft technique is beneficial to the patient. The rationale of revascularization in the early phase of acute myocardial infarction is to minimize the area of muscle necrosis by increasing perfusion to the ischemic myocardium around the infarct.     

TIPS联合搅拌溶栓治疗肝硬化急性门静脉血栓的临床疗效分析

目的探讨经颈静脉肝内门体分流术(TIPS)联合搅拌溶栓治疗肝硬化急性门静脉血栓的临床疗效。方法回顾性分析2014年1月至2017年12月河南科技大学第一附属医院连续收治的37例肝硬化急性门静脉血栓患者资料,其中男性20例,女性17例,年龄29~71岁。按治疗方案不同分为联合组5二15)与抗凝组5=22)。联合组接受TIPS联合搅拌溶栓以及抗凝药物治疗。抗凝组仅接受抗凝药物治疗。比较两组肝功能、门静脉血流动力学等变化。随访患者术后门静脉通畅、出血以及生存情况等。结果联合组术后门静脉压力和门静脉最大负荷低于术前,门静脉最大血容量和门静脉血流速度髙于术前,差异有统计学意义(均P<0.05)。联合组术后2周、6个月.12个月门静脉最大负荷分别为(13.9±5.4)%、(16.1±5.5)%、(13.8±6.2)%,低于抗凝组的(84.1±31.3)%、(85.9±27.6)%、(88.2±39.5)%,差异有统计学意义(均P<0.05)。联合组术后2周、6个月、12个月门静脉血流速度分别为(21.6±5.7cm/s、(16.1±6.3)cm/s、(17.6±4.9)cm/s,高于抗凝组的(9.7±4.6)cm/s、(8.1±4.3)cm/s、(8.2±3.5)cm/s,差异有统计学意义(均P<0.05)。联合组术后3例患者门静脉血栓复发,其余患者门静脉及分流道血流通畅。抗凝组仅3例门静脉血流通畅。联合组累积无消化道出血率优于抗凝组。联合组累积生存率优于抗凝组,差异有统计学意义(P<0.05)。结论TIPS联合搅拌溶栓治疗肝硬化急性门静脉血栓的疗效尚可,且优于传统抗凝治疗。     

门静脉血栓形成的诊断与治疗

目的：探讨门静脉血栓形成的诊断与治疗方法。方法：15例门静脉血栓形成患者行抗凝、溶栓、祛聚治疗。结果：6例门静脉部分或完全再通,2例出现小肠坏死转为手术治疗,1例死亡,6例好转。手术患者无并发症和死亡。15例2周后血清D-dimmer水平明显下降（P〈0.05）。结论：门静脉血栓形成应早期诊断,根据具体的病情选择合理的治疗方法。     

丹参活血汤联合电疗治疗自发性膝关节骨坏死微创置换术后肿胀疼痛的效果

目的:分析丹参活血汤联合电疗治疗自发性膝关节骨坏死微创置换术后肿胀疼痛的效果.方法:以2017年5月—2019年11月间本院收治的92例自发性膝关节骨坏死微创置换患者为对象,随机分为两组,各46例.对照组术后予以中频电疗,试验组术后予以丹参活血汤联合中频电疗,对比分析两组患肢肿胀程度、患肢静息及活动状态疼痛程度、膝关节...     

腹部手术对老年心脑血管病患者的影响

目的探讨老年患者腹部手术后心脑血管意外的发病特点及防治体会。 方法回顾性分析2011年1月至2013年12月本科室诊治的64例腹腔手术后发生心脑血管意外的老年患者临床资料,其中32例伴有心脑血管疾病为A组,同期无心脑血管疾病的32例行腹腔手术的患者为B组,探讨其发病的原因及防治方法。 结果A组术后11例发生了脑梗死,其中6例为脑栓塞,4例发生脑出血,心肌梗死6例,心电图有心肌缺血5例,ST段改变9例,急性心力衰竭2例,心律失常5例; B组术后3例发生了脑梗死,其中1例为脑栓塞,1例发生脑出血,心肌梗死1例,心电图有心肌缺血2例,ST段改变2例,心律失常1例。A组术后心脑血管疾病的发生率明显高于B组,组间差异有统计学意义(P < 0.05)。 结论患有腔隙性脑梗死、陈旧性脑梗死、心肌梗死、心肌缺血、ST段改变等心脑血管疾病的患者手术风险高,易出现猝死及心脑血管意外,必须引起临床医师的注意和重视。     

Partial Splenic Embolization Versus Splenectomy for the Management of Hypersplenism in Cirrhotic Patients

Background  Hypersplenism occurs in patients with chronic liver disease, and splenectomy is the definitive treatment. However, the operation may be hazardous in patients with poor liver function. In recent years, partial splenic embolization (PSE) has been widely used in patients with hypersplenism and cirrhosis. This study was conducted to assess the safety and efficacy of PSE compared to splenectomy in the management of hypersplenism in cirrhotic patients. Methods  This study comprised 40 patients with hypersplenism secondary to cirrhosis. They were divided into two groups, each including 20 patients. The first group of patients were treated by PSE using polyvinyl alcohol particles to achieve embolization of at least 50% of the distal branches of the splenic artery. Postembolization arteriography and computed tomography were performed to document the extent of devascularization. Patients in the second group were treated by splenectomy with or without devascularization and left gastric ligation according to the presence or absence of esophageal varices. Results  There was marked improvement in platelet and leukocytic counts in both groups, and the counts remained at appropriate levels during the follow-up period. All patients in the first group had problems related to postembolization syndrome that abated by the first week. One patient in the first group died from myocardial infarction. No deaths occurred in the second group. Asymptomatic portal vein thrombosis developed in one patient in the first group that was treated with anticoagulation, and another patient developed splenic abscess treated by splenectomy with a good outcome. In the second group, three patients developed portal vein thrombosis, one of them being readmitted 4 months postoperatively with mesenteric vascular occlusion; that patient underwent a resection anastomosis with good outcome. Conclusions  Partial splenic embolization is an effective therapeutic modality for the treatment of hypersplenism secondary to chronic liver disease. It is a simple, rapid procedure that is easily performed under local anesthesia; and it allows preservation of adequate splenic tissue to safeguard against overwhelming infection.     

Pharmacomechanical thrombolysis for phlegmasia cerulea dolens

Phlegmasia cerulea dolens (PCD) is limb-threatening. Traditional treatments are very morbid. We examine the efficacy of percutaneous treatment of PCD. Between May 2005 and September 2008, we treated 21 limbs in 20 patients with lower extremity PCD who were candidates for thrombolysis. Diagnosis was by clinical examination and duplex ultrasound. Catheter access to the deep venous system was obtained through a popliteal vein. Therapy used pulse spray thrombolysis with tissue plasminogen activator (tPA). Infusion catheters and adjunctive percutaneous techniques were used as indicated. Postoperatively, patients were treated with systemic anticoagulation, compression hose, and interval follow-up. Limbs were graded according to the CEAP classification. Twenty patients (13 male) were treated with a mean age of 55.8 years. Nine patients had hypercoagulable states, four May Thurner syndrome, three a history of cancer, one postcolon resection, one acute myocardial infarction, and one postfemoral vein puncture. All patients had resolution of PCD without the need for open surgery. The initial tPA dose was 19.5 mg with pulse spray thrombolysis. Infusion catheters were required in 18 patients and used for 16.1 hours (range, 8 to 36 hours) until complete thrombolysis. Venous angioplasty was necessary in 14 patients with nine of these requiring venous stents. One patient required above-knee amputation despite successful treatment of her PCD. Mean follow-up was 10.7 months (range, 1 to 39 months). All patients demonstrated no or minimal residual thrombus and intact valvular function and a mean clinical CEAP score of 2.4. Percutaneous treatment of PCD produced excellent results with minimal morbidity.     

Acute mesenteric venous thrombosis: case for nonoperative management

OBJECTIVE: Initial treatment in the management of acute mesenteric vein thrombosis (MVT) is controversial. Some authors have proposed a surgical approach, whereas others have advocated medical therapy (anticoagulation). In this study, we analyzed and compared the results obtained with surgical and medical treatment to determine the best initial management for this disease. METHODS: We retrospectively reviewed the records of patients treated for MVT in a secondary care surgical department from January 1987 to December 1999. Before January 1995, our departmental policy was to perform surgery in patients with suspected MVT. Since January 1995, we have preferred a medical approach when achievable. Each patient in this study was assessed for diagnosis, initial management (laparotomy or anticoagulation), morbidity, mortality, duration of hospitalization, the need for secondary operation, portal hypertension, and survival rates. RESULTS: Twenty-six patients were treated, 14 before January 1995 (group 1) and 12 since January 1995 (group 2). Morbidity, mortality, secondary operation, portal hypertension, and 2-year survival rates were 34.6%, 19.2%, 15.3%, 19.2%, and 76.9%, respectively. No statistical difference was observed between the two groups. The mean duration of hospitalization was 51.6 days in group 1 and 23.2 days in group 2 (P < .05). Among the 12 patients treated by means of laparotomy with bowel resection, 10 patients (83%) had mucosal necrosis without transmural necrosis at pathologic study. CONCLUSION: Nonoperative management for acute MVT is feasible when the initial diagnosis with a computed tomography scan is certain and when the bowel infarction has not led to transmural necrosis and bowel perforation. The morbidity, mortality, and survival rates are similar in cases of surgical and nonoperative management. The length of hospital stay is shorter when patients are treated with a nonoperative approach. A nonoperative approach, when indicated, avoids the resection of macroscopically infarcted small bowel (without transmural necrosis) in cases that are potentially reversible with anticoagulation alone.